Latest News - Truist Financial
Top Corporates Hub
Truist Financial
JPMorgan Reinstates Devon Energy (DVN) as Overweight on Valuation Appeal
10.06.2026 03:22
Devon Energy Corporation (NYSE:DVN) is included among the 10 Best Dividend Stocks to Buy According to D. E. Shaw. On June 8, JPMorgan reinstated coverage of Devon Energy Corporation (NYSE:DVN) with an Overweight rating. It also set a $62 price target on the stock after a period of restriction. The firm believes the stock’s current […]
JPMorgan Reinstates Devon Energy (DVN) as Overweight on Valuation Appeal
10.06.2026 03:22
Devon Energy Corporation (NYSE:DVN) is included among the 10 Best Dividend Stocks to Buy According to D. E. Shaw. On June 8, JPMorgan reinstated coverage of Devon Energy Corporation (NYSE:DVN) with an Overweight rating. It also set a $62 price target on the stock after a period of restriction. The firm believes the stock’s current […]
META Stock Rebounds Overnight: Analyst Says Subscriptions Could Be $20B Business By 2030
10.06.2026 03:06
The features could garner 360 million paid subscribers, generating revenue equivalent to roughly 5% of Meta’s total sales.
META Stock Rebounds Overnight: Analyst Says Subscriptions Could Be $20B Business By 2030
10.06.2026 03:06
The features could garner 360 million paid subscribers, generating revenue equivalent to roughly 5% of Meta’s total sales.
How The Truist Financial (TFC) Story Is Shifting As Analyst Views Diverge
09.06.2026 14:11
The latest update keeps Truist Financial's published fair value estimate steady at $55.67, while analyst price targets around the stock have been moving in different directions. Some researchers are trimming targets on valuation concerns, while others are nudging them higher as they revisit assumptions about the core banking business and earnings stability. As you read on, you will see how this evolving mix of target cuts and hikes shapes the broader narrative and what to watch to stay on top...
Truist Raises Snowflake Inc. (SNOW) Price Target to $300 from $275
09.06.2026 13:39
Snowflake Inc. (NYSE:SNOW) is one of the 10 Best AI Stocks to Buy in June. On June 5, TheFly reported that Truist increased its price target on Snowflake to $300 from $275 while maintaining a Buy rating on the shares, following the company’s Investor Day presentation on June 2. The analyst noted that Snowflake’s Cortex Code […]
Psyched about the SpaceX IPO? Don't forget the brutal lesson from Facebook's IPO.
09.06.2026 13:38
The excitement is building around the SpaceX IPO, which is set to debut on the Nasdaq Composite on Friday.
Market Chatter: Truist Looks to Expand in $1.8 Trillion CMBS Servicing Market Through Grandbridge
09.06.2026 12:59
Truist Financial (TFC) is preparing to expand its presence in the $1.8 trillion commercial mortgage-
Grandbridge launches Master Servicing following ratings approval, expanding Truist's Commercial Mortgage Servicing Business
09.06.2026 12:30
Grandbridge Real Estate Capital, a wholly owned subsidiary of Truist Bank and Truist Bank's parent company, Truist Financial Corporation (NYSE: TFC), today announced the launch of its Master Servicing platform. This marks a significant expansion in Grandbridge's commercial mortgage servicing capability and further strengthens Truist as a national leader in commercial real estate.
How The Taylor Morrison (TMHC) Story Is Evolving After The Berkshire Deal And Capital Moves
08.06.2026 08:06
Taylor Morrison Home just saw its fair value estimate trimmed from about US$70.22 to roughly US$66.43 per share, narrowing the gap with the agreed US$72.50 offer price that is front of mind for many investors. This adjustment comes alongside fresh analyst commentary around index inclusion signals, potential M&A activity, and the impact of recent share repurchases and new community plans. Read on to see what this evolving narrative could mean for how you track the stock from here. Stay updated...
How The Taylor Morrison (TMHC) Story Is Evolving After The Berkshire Deal And Capital Moves
08.06.2026 08:06
Taylor Morrison Home just saw its fair value estimate trimmed from about US$70.22 to roughly US$66.43 per share, narrowing the gap with the agreed US$72.50 offer price that is front of mind for many investors. This adjustment comes alongside fresh analyst commentary around index inclusion signals, potential M&A activity, and the impact of recent share repurchases and new community plans. Read on to see what this evolving narrative could mean for how you track the stock from here. Stay updated...
Barclays Reiterates Overweight Rating on Entergy Corp. (ETR)
08.06.2026 05:57
Entergy Corp. (NYSE:ETR) is one of the 11 best regulated electric stocks to buy now. On June 3, Barclays reduced the price target on Entergy Corp. (NYSE:ETR) from $124 to $119. The firm retained an Overweight rating on the stock. As per the firm, the stock performance has been lackluster since the first quarter’s report, […]
BMO Capital Reaffirms Outperform Rating for CMS Energy (CMS)
08.06.2026 05:41
CMS Energy Corp. (NYSE:CMS) is one of the 11 best regulated electric stocks to buy now. On June 4, BMO Capital analyst James Thalacker maintained an Outperform rating on CMS Energy Corp. (NYSE:CMS) and reduced the price target from $82 to $81. This revision follows a fresh regulatory filing by the company’s subsidiary, Consumers Energy, […]
Is Rapport Therapeutics (RAPP) Using RAP-219 To Redefine Its Broader Neuroscience Investment Narrative?
08.06.2026 02:08
In late May 2026, analysts BTIG and Truist highlighted Rapport Therapeutics’ RAP-219 program after the company reported progress toward Phase 3 trials, supported by earlier Phase 2a follow-up data. An interesting angle is how RAP-219’s dual focus on epilepsy and bipolar mania, including a planned long-acting injectable, could broaden Rapport’s clinical opportunity set. We’ll now examine how this momentum in RAP-219, particularly its Phase 3 preparation, influences Rapport Therapeutics’...
Is Rapport Therapeutics (RAPP) Using RAP-219 To Redefine Its Broader Neuroscience Investment Narrative?
08.06.2026 02:08
In late May 2026, analysts BTIG and Truist highlighted Rapport Therapeutics’ RAP-219 program after the company reported progress toward Phase 3 trials, supported by earlier Phase 2a follow-up data. An interesting angle is how RAP-219’s dual focus on epilepsy and bipolar mania, including a planned long-acting injectable, could broaden Rapport’s clinical opportunity set. We’ll now examine how this momentum in RAP-219, particularly its Phase 3 preparation, influences Rapport Therapeutics’...
How The CMS Proposal Is Recasting The Community Health Systems (CYH) Investment Story
07.06.2026 18:08
Analysts have trimmed their fair value estimate for Community Health Systems from US$3.49 to US$3.31 per share, a modest adjustment that reflects more cautious modeling. The change lines up with recent research describing the proposed CMS rule as neutral to slightly negative for hospitals and taking a more conservative stance on revenue and margins. As you read on, you will see how these evolving assumptions are shaping the narrative around risk, earnings power, and what to watch...
HELOC and home equity loan rates Sunday, June 7, 2026: Truist stays Yahoo's top HELOC lender in June
07.06.2026 10:00
These are today's HELOC and home equity loan interest rates, Sunday, June 7, 2026. According to Curinos, the average HELOC rate is 7.25%. The national average rate on a home equity loan is 7.86%, which matches the 2026 low first observed in mid-March.
ONE Gas (OGS) Faces Target Reduction in Morgan Stanley’s Utility Sector Update
05.06.2026 02:29
ONE Gas, Inc. (NYSE:OGS) is included among the 10 Oversold Dividend Growth Stocks to Buy. On May 21, Morgan Stanley lowered its price recommendation on ONE Gas, Inc. (NYSE:OGS) to $82 from $86. It reiterated an Equal Weight rating on the shares. The adjustment came as part of the firm’s update to price targets for […]
Morgan Stanley Raises its Price Target on Block (XYZ)
04.06.2026 16:49
Block, Inc. (NYSE:XYZ) is one of the 15 Most Promising Stocks to Buy Right Now. On May 29, 2026, Morgan Stanley analyst James Faucette raised the firm’s price target on Block, Inc. (NYSE:XYZ) to $98 from $96 and maintained an Overweight rating on the shares. Faucette cited Morgan Stanley’s proprietary AlphaWise survey of about 274 […]
Truist Raises PT On Amazon.com (AMZN) To $320, Reiterates “Buy” Rating
04.06.2026 16:11
On the back of strong confidence from hedge funds and Wall Street, Amazon.com, Inc. (NASDAQ:AMZN) is one of the best AI infrastructure stocks, with upside potential of 16.4%. Amazon.com, Inc. (NASDAQ:AMZN)’s cloud business has already served as the backbone of the AI buildout. Yet a ten-year, $100 billion commitment from Anthropic indicates that growth is […]